|
Fluvastatin sodium
|
氟伐他汀鈉
|
93957-55-2
|
|
IPA-3
|
IPA-3
|
42521-82-4
|
|
KX2-391
|
5-[4-[2-(4-嗎啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺
|
897016-82-9
|
|
T-5224
|
T-5224
|
530141-72-1
|
|
ATN-161
|
262438-43-7
|
262438-43-7
|
|
Crenolanib (CP-868596)
|
1-[2-[5-(3-甲基氧雜環(huán)丁烷-3-基甲氧基)苯并咪唑-1-基]喹啉-8-基]哌啶-4-基]胺
|
670220-88-9
|
|
AZD1208
|
AZD1208
|
1204144-28-4
|
|
UNC1999
|
UNC1999
|
1431612-23-5
|
|
PTC-209
|
PTC-209
|
315704-66-6
|
|
KIRA6
|
CS-2625
|
1589527-65-0
|
|
2-cyano-3-(1-phenylindol-3-yl)acrylate
|
UK 5099
|
56396-35-1
|
|
EHT 1864
|
EHT 1864
|
754240-09-0
|
|
Fatostatin A Hydrobromide
|
FATOSTATIN
|
298197-04-3
|
|
Tanzisertib
|
TANZISERTIB
|
899805-25-5
|
|
TMP-195
|
TMP195游離態(tài)
|
1314891-22-9
|
|
K02288
|
K02288
|
1431985-92-0
|
|
SF1670(PTENinhibitor)
|
SF1670(PTENINHIBITOR)
|
345630-40-2
|
|
NMS-P937 (NMS1286937)
|
4,5-二氫-1-(2-羥基乙基)-8-[[5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯基]氨基]-1H-吡唑并[4,3-H]喹唑啉-3-甲酰胺
|
1034616-18-6
|
|
Imaradenant (AZD4635)
|
AZD4635
|
1321514-06-0
|
|
Thieno[3,2-c]pyridine-5(4H)-acetic acid,a-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (aS)-, sulfate (1:1)
|
硫酸氯吡格雷
|
120202-66-6
|
|
eflornithine ,eflornithine hydrochloride hydrate
|
依氟鳥氨酸鹽酸鹽一水合物
|
96020-91-6
|
|
4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione
|
4-芐基-2-(萘-1-基)-[1,2,4]噻二唑烷-3,5-二酮
|
865854-05-3
|
|
LMK-235
|
N-[[6-(羥基氨基)-6-氧代己基]氧基]-3,5-二甲基-苯甲酰胺
|
1418033-25-6
|
|
Afuresertib
|
GSK-2110183C
|
1047644-62-1
|
|
1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one
|
波齊替尼
|
1092364-38-9
|
|
SP2509
|
無中文名稱
|
1423715-09-6
|
|
Mivebresib
|
米維布塞
|
1445993-26-9
|
|
Mavacamten
|
瑪伐凱泰
|
1642288-47-8
|
|
PKM2-IN-1
|
COMPOUND 3K
|
94164-88-2
|
|
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-Trimethyldecahydro-3H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-ol
|
雙氫青蒿素
|
71939-50-9
|
|
DC661
|
DC661
|
1872387-43-3
|
|
BMS-1166
|
BMS-1166
|
1818314-88-3
|
|
Lonafarnib
|
洛那法尼
|
193275-84-2
|
|
Elesclomol
|
伊利司莫
|
488832-69-5
|
|
BMS303141
|
BMS303141
|
943962-47-8
|
|
PND-1186
|
PND1186
|
1061353-68-1
|
|
SKL2001
|
SKL2001
|
909089-13-0
|
|
Salubrinal
|
SALUBRINAL
|
405060-95-9
|
|
Pifithrin-μ
|
Pifithrin-渭
|
64984-31-2
|
|
E-64
|
N-(反式-環(huán)氧丁二酰基)-L-亮氨酸-4-胍基丁基酰胺
|
66701-25-5
|
|
Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-ar-carboxylic acid, 3',6'-bis(acetyloxy)-3-oxo-, 2,5-dioxo-1-pyrrolidinyl ester
|
5(6)-羧基二乙酸熒光素琥珀酰亞胺酯
|
150347-59-4
|
|
Rimonabant
|
利莫那班
|
168273-06-1
|
|
GW6471
|
GW 6471
|
880635-03-0
|
|
Cryptotanshinone
|
隱丹參酮
|
35825-57-1
|
|
Cilengitide TFA
|
西侖吉肽TFA鹽
|
199807-35-7
|
|
NVP-TNKS656
|
NVP-TNKS656
|
1419949-20-4
|
|
ODM-201
|
達(dá)洛魯胺
|
1297538-32-9
|
|
OICR-9429
|
N-(4-(4-甲基哌嗪-1-基)-3'-(嗎啉代甲基)-[1,1'-聯(lián)苯]-3-基)-6-氧代-4-(三氟甲基)-1,6-二氫吡啶-3-甲酰胺
|
1801787-56-3
|
|
PF-543 hydrochloride
|
PF-543
|
1706522-79-3
|
|
dBET6
|
1950634-92-0
|
1950634-92-0
|
|
RU.521
|
RU320521
|
2262452-06-0
|
|
AG490
|
酪氨酸磷酸化抑制劑AG 490
|
133550-30-8
|
|
GSK2879552 dihydrochloride
|
GSK2879552
|
1902123-72-1
|
|
Refametinib
|
瑞法替尼
|
923032-37-5
|
|
BMS 777607
|
N-[4-[(2-氨基-3-氯吡啶-4-基)氧基]-3-氟苯基]-4-乙氧基-1-(4-氟苯基)-2-氧代-1,2-二氫吡啶-3-甲酰胺
|
1025720-94-8
|
|
PCI-34051
|
N-羥基-1-(4-甲氧基芐基)-1H-吲哚-6-甲酰胺
|
950762-95-5
|
|
JIB-04
|
5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亞甲基)腙
|
199596-05-9
|
|
SGC-CBP30
|
SGC-CBP30
|
1613695-14-9
|
|
AZD5582
|
AZD 5582
|
1258392-53-8
|
|
Ac-CoA Synthase Inhibitor1
|
1-(2,3-二(噻吩-2-基)喹啉-6-基)-3-(2-甲氧基乙基)脲
|
508186-14-9
|
|
WZB-117
|
WZB-117
|
1223397-11-2
|
|
STO-609
|
STO-609
|
52029-86-4
|
|
GSK2334470
|
GSK2334470
|
1227911-45-6
|
|
GSK2656157
|
GSK2656157
|
1337532-29-2
|
|
OSS_128167
|
OSS-128167
|
887686-02-4
|
|
9-[(2-Hydroxyethoxy)Methyl]Guanine
|
阿昔洛韋
|
59277-89-3
|
|
SCH900776
|
6-溴-3-(1-甲基-1H-吡唑-4-基)-5-(3R)-3-哌啶基吡唑并[1,5-A]嘧啶-7-胺
|
891494-63-6
|
|
Carbamic acid, N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-, ethyl ester
|
HDAC抑制劑
|
1477949-42-0
|
|
3',4',5,7-Tetrahydroxyflavone
|
木犀草素
|
491-70-3
|
|
A-1210477
|
無中文名稱
|
1668553-26-1
|
|
BAY-876
|
BAY-876
|
1799753-84-6
|
|
PNU-74654
|
PNU 74654,2-PHENOXYBENZOICACID-[(5-METHYL-2-FURANYL)METHYLENE]HYDRAZIDE
|
113906-27-7
|
|
AMG900
|
AMG 900
|
945595-80-2
|
|
Degrasyn
|
WP1130
|
856243-80-6
|
|
Pacritinib
|
帕克替尼
|
937272-79-2
|
|
NMS 873
|
NMS873
|
1418013-75-8
|
|
4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4E)-
|
霉酚酸
|
24280-93-1
|
|
THZ531
|
THZ531
|
1702809-17-3
|
|
Thiomyristoyl
|
1429749-41-6
|
1429749-41-6
|
|
KN-62
|
1-[N,O-二(5-異喹啉磺?；?-N-甲基-L-型酪氨酸]-4-苯基哌嗪
|
127191-97-3
|
|
Geldanamycin
|
格爾德霉素
|
30562-34-6
|
|
FB23-2
|
FB23-2
|
2243736-45-8
|
|
GW 4064
|
3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-異丙基異惡唑
|
278779-30-9
|
|
TED-347
|
化合物TED-347
|
2378626-29-8
|
|
Daptomycin
|
達(dá)托霉素
|
103060-53-3
|
|
LW6
|
LW 6
|
934593-90-5
|
|
Bafetinib
|
巴氟替尼
|
859212-16-1
|
|
I-BET151
|
7-(3,5-二甲基異噁唑-4-基)-8-甲氧基-1-((R)-1-(吡啶-2-基)乙基)-1H-咪唑并[4,5-C]喹啉-2(3H)-酮
|
1300031-49-5
|
|
Omecamtiv mecarbil (CK-1827452)
|
4-[[2-氟-3-[N'-(6-甲基吡啶-3-基)脲基]苯基]甲基]哌嗪-1-羧酸甲酯
|
873697-71-3
|
|
Pioglitazone
|
匹格列酮
|
111025-46-8
|
|
10074- 5
|
N-2-聯(lián)苯基-7-硝基-2,1,3-苯并惡二唑-4-胺
|
413611-93-5
|
|
ARN-509
|
阿帕魯胺
|
956104-40-8
|
|
EPZ004777
|
EPZ004777
|
1338466-77-5
|
|
SAR 131675
|
SAR131675
|
1433953-83-3
|
|
GS-9973
|
GS-9973
|
1229208-44-9
|
|
Vps34-IN-1
|
VPS34-IN1
|
1383716-33-3
|
|
Paxalisib (GDC-0084)
|
GDC-0084
|
1382979-44-3
|
|
Siremadlin
|
NVP-HDM201
|
1448867-41-1
|
|
4'-Chloro-6-((4-chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-ol
|
MYCi975
|
2289691-01-4
|
|
Elacridar
|
依克立達(dá)
|
143664-11-3
|